Thyroid angiosarcoma (TAS) is rare and represents a very aggressive malignancy. Its rarity is principally linked to two major pitfalls. Firstly, TAS histopathology diagnosis can be difficult; second, the limited clinical experience with this condition can make its management complex. We conducted a detailed systematic review, focusing on the knowledge available regarding TAS etiopathogenesis, treatment options and prognosis. The aim is to present the main TAS characteristics and to summarize the clinical experiences described worldwide, in order to provide a useful clinical tool.
Primary thyroid angiosarcoma: a systematic review / De Felice, F.; Moscatelli, E.; Orelli, S.; Bulzonetti, N.; Musio, D.; Tombolini, V.. - In: ORAL ONCOLOGY. - ISSN 1368-8375. - 82:(2018), pp. 48-52. [10.1016/j.oraloncology.2018.05.004]
Primary thyroid angiosarcoma: a systematic review
De Felice, F.
Primo
;Orelli, S.;Tombolini, V.Ultimo
2018
Abstract
Thyroid angiosarcoma (TAS) is rare and represents a very aggressive malignancy. Its rarity is principally linked to two major pitfalls. Firstly, TAS histopathology diagnosis can be difficult; second, the limited clinical experience with this condition can make its management complex. We conducted a detailed systematic review, focusing on the knowledge available regarding TAS etiopathogenesis, treatment options and prognosis. The aim is to present the main TAS characteristics and to summarize the clinical experiences described worldwide, in order to provide a useful clinical tool.| File | Dimensione | Formato | |
|---|---|---|---|
|
De-Felice_Primary_2018.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
219.25 kB
Formato
Adobe PDF
|
219.25 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
